Page last updated: 2024-10-18

dihydroxyphenylalanine and Convulsions, Grand Mal

dihydroxyphenylalanine has been researched along with Convulsions, Grand Mal in 1 studies

Dihydroxyphenylalanine: A beta-hydroxylated derivative of phenylalanine. The D-form of dihydroxyphenylalanine has less physiologic activity than the L-form and is commonly used experimentally to determine whether the pharmacological effects of LEVODOPA are stereospecific.
dopa : A hydroxyphenylalanine carrying hydroxy substituents at positions 3 and 4 of the benzene ring.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Biraben, A1
Semah, F1
Ribeiro, MJ1
Douaud, G1
Remy, P1
Depaulis, A1

Clinical Trials (1)

Trial Overview

TrialPhaseEnrollmentStudy TypeStart DateStatus
"Dopaminergic Reactivity In Idiopathic Generalized Epilepsy: A Proof Of Concept Clinical, Pharmacological And Neurophysiological Study"[NCT01432821]31 participants (Actual)Interventional2011-09-30Completed
[information is prepared from clinicaltrials.gov, extracted Sep-2024]

Other Studies

1 other study available for dihydroxyphenylalanine and Convulsions, Grand Mal

ArticleYear
PET evidence for a role of the basal ganglia in patients with ring chromosome 20 epilepsy.
    Neurology, 2004, Jul-13, Volume: 63, Issue:1

    Topics: Adolescent; Adult; Anticonvulsants; Caudate Nucleus; Chromosome Disorders; Chromosomes, Human, Pair

2004